PL3317672T3 - Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału - Google Patents

Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału

Info

Publication number
PL3317672T3
PL3317672T3 PL16736595T PL16736595T PL3317672T3 PL 3317672 T3 PL3317672 T3 PL 3317672T3 PL 16736595 T PL16736595 T PL 16736595T PL 16736595 T PL16736595 T PL 16736595T PL 3317672 T3 PL3317672 T3 PL 3317672T3
Authority
PL
Poland
Prior art keywords
biomarkers
cell
stool samples
free nucleosomes
nucleosomes
Prior art date
Application number
PL16736595T
Other languages
English (en)
Inventor
Jacob MICALLEF
Marielle HERZOG
Original Assignee
Belgian Volition Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belgian Volition Sprl filed Critical Belgian Volition Sprl
Publication of PL3317672T3 publication Critical patent/PL3317672T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL16736595T 2015-07-01 2016-07-01 Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału PL3317672T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1511542.1A GB201511542D0 (en) 2015-07-01 2015-07-01 Use of cell free nucleosomes as biomarkers
PCT/GB2016/051995 WO2017001864A1 (en) 2015-07-01 2016-07-01 Use of cell-free nucleosomes as biomarkers in fecal samples
EP16736595.6A EP3317672B1 (en) 2015-07-01 2016-07-01 Use of cell-free nucleosomes as biomarkers in fecal samples

Publications (1)

Publication Number Publication Date
PL3317672T3 true PL3317672T3 (pl) 2020-10-05

Family

ID=53872511

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16736595T PL3317672T3 (pl) 2015-07-01 2016-07-01 Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału

Country Status (8)

Country Link
US (1) US20180305759A1 (pl)
EP (1) EP3317672B1 (pl)
DK (1) DK3317672T3 (pl)
ES (1) ES2775178T3 (pl)
GB (1) GB201511542D0 (pl)
HR (1) HRP20200229T1 (pl)
PL (1) PL3317672T3 (pl)
WO (1) WO2017001864A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220262462A1 (en) 2019-04-10 2022-08-18 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computational filtering of methylated sequence data for predictive modeling
IL293342B1 (en) * 2019-12-02 2026-01-01 Belgian Volition Srl Using cell-free nucleosomes as biomarkers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
PT2788767T (pt) * 2011-12-07 2017-12-06 Belgian Volition Sprl Método de detecção de adutos de nucleosoma
GB201303575D0 (en) * 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes

Also Published As

Publication number Publication date
US20180305759A1 (en) 2018-10-25
ES2775178T3 (es) 2020-07-24
HRP20200229T1 (hr) 2020-11-13
GB201511542D0 (en) 2015-08-12
DK3317672T3 (da) 2020-03-16
EP3317672B1 (en) 2019-12-11
WO2017001864A1 (en) 2017-01-05
EP3317672A1 (en) 2018-05-09

Similar Documents

Publication Publication Date Title
IL283965A (en) Antibodies against cd73 and uses thereof
IL257324A (en) Antibody against glypican-3 and application thereof
PL3288719T3 (pl) Zestaw użytkowy
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
IL251972B (en) Analyzing and utilizing landscapes
PL3353210T3 (pl) Przeciwciała anty-TIGIT i sposoby stosowania
BR112016018521A2 (pt) composição, e, kit.
DK3099172T3 (da) Modificeret biologisk bekæmpelsesmiddel og anvendelser deraf
HUE055233T2 (hu) Az EGFR gátló és annak elkészítése és alkalmazása
BR112016021626A2 (pt) indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas
DK3018183T3 (da) Halogenolefinbaseret sammensætning og anvendelse deraf
PL3341664T3 (pl) Sposób obsługi urządzenia chłodniczego i urządzenie chłodnicze
DK3410970T3 (da) Forankringsskrue med kondenseringsattributter
DK3233105T3 (da) Hidtil ukendt kombination og anvendelse
SI3290441T1 (sl) RGMA-vezavni protein in njegova uporaba
PL3018979T3 (pl) Sposób działania i rozbudowy sieci oświetleniowej
GB201511512D0 (en) Use of cell-free nucleosomes as biomarkers
DK3476830T3 (da) Polymethinforbindelser og anvendelse deraf som fluorescerende markører
KR20180085008A (ko) 항-pcsk9 항체 및 그의 용도
BR112017010263A2 (pt) fluidos e método incluindo nanocelulose
IL274953A (en) Unit operation and use thereof
DK3266310T3 (da) Nukleotidsammensætning og anvendelse i fødevare deraf
DK3095385T3 (da) Manometrisk probe
BR112017013928A2 (pt) composição alimentar e método de uso.
PL3317672T3 (pl) Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału